# PFXNZ (Phenixfin Corporation) - SEC EDGAR Financial Statements

> Phenixfin Corporation reported $309.9M in total assets and net income of $4.67M through September 30, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/PFXNZ
- Markdown: https://convexityos.com/fundamentals/PFXNZ.md
- SEC CIK: 0001490349
- Reporting currency: USD
- Latest filing period: June 30, 2026
- Last synced: Nov 20, 2026, 05:50 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001490349&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Sep 30, 2025 |
| Operating Income | FY 2025 | -- | Operating profit |
| Net Income | FY 2025 | $4.67M | GAAP bottom line |
| Diluted EPS | FY 2025 | $2.42 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Jun 30, 2026 | $2.20M | Total debt: $2.46M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Interest Income | $16.61M | $14.30M | $12.15M | $9.16M |
| Interest Expense | $10.28M | $6.61M | $5.53M | $5.11M |
| **Net Income** | $4.16M | $18.62M | $26.92M | -$6.11M |
| Basic EPS | $2.06 | $9.13 | $12.87 | -$2.63 |
| **Diluted EPS** | $2.06 | $9.13 | $12.87 | -$2.63 |
| Basic Shares Outstanding | 2.0M | 2.0M | 2.1M | 2.3M |
| Diluted Shares Outstanding | 2.0M | 2.0M | 2.1M | 2.3M |

### Income Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Interest Income | $4.36M | $4.13M | $3.87M | $4.25M | $4.58M | $3.85M | $3.77M | $3.71M |
| Interest Expense | $2.32M | $2.31M | $2.43M | $2.49M | $2.66M | $2.58M | $2.55M | $1.78M |
| **Net Income** | $4.22M | $1.13M | -$4.77M | $4.08M | -$1.50M | -$896K | $2.46M | $6.10M |
| Basic EPS | $2.19 | $0.57 | -$2.38 | -- | -$0.74 | -$0.44 | $1.22 | -- |
| **Diluted EPS** | $2.19 | $0.57 | -$2.38 | -- | -$0.74 | -$0.44 | $1.22 | -- |
| Basic Shares Outstanding | 1.9M | 2.0M | 2.0M | -- | 2.0M | 2.0M | 2.0M | -- |
| Diluted Shares Outstanding | 1.9M | 2.0M | 2.0M | -- | 2.0M | 2.0M | 2.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $7.30M | $67.60M | $6.00M | $22.80M |
| Short-Term Investments | -- | -- | $79.06M | -- |
| **Cash & Short-Term Investments** | $7.30M | $67.60M | $85.06M | $22.80M |
| Accounts Receivable, Net | -- | -- | $3.94M | -- |
| Other Non-Current Assets | -- | -- | $833K | $1.19M |
| **Total Assets** | $316.9M | $302.8M | $239.7M | $218.9M |
| Deferred Revenue (Current) | -- | -- | $422K | -- |
| Deferred Revenue (Non-Current) | -- | -- | $422K | -- |
| **Total Liabilities** | $156.1M | $142.4M | $92.99M | $98.03M |
| **Total Debt (incl. Leases)** | $2.44M | $294K | -- | -- |
| Common Stock | $2.0K | $2.0K | $2.1K | $2.1K |
| Retained Earnings | -$543.9M | -$544.6M | -$548.1M | -$554.6M |
| **Total Stockholders' Equity** | $160.8M | $160.3M | $146.7M | $120.8M |
| Total Equity | $160.8M | $160.3M | $146.7M | $120.8M |

### Balance Sheet (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.20M | $3.10M | $3.40M | $7.30M | $7.30M | $8.70M | $7.20M | $67.60M |
| **Cash & Short-Term Investments** | $2.20M | $3.10M | $3.40M | $7.30M | $7.30M | $8.70M | $7.20M | $67.60M |
| **Total Assets** | $309.9M | $305.6M | $307.4M | $316.9M | $306.8M | $300.7M | $311.9M | $302.8M |
| **Total Liabilities** | $152.0M | $151.8M | $151.6M | $156.1M | $150.1M | $141.7M | $149.2M | $142.4M |
| **Total Debt (incl. Leases)** | $2.46M | $2.50M | $2.48M | $2.44M | $191K | $223K | -- | $294K |
| Common Stock | $1.9K | $1.9K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| Retained Earnings | -$543.4M | -$547.5M | -$548.6M | -$543.9M | -$547.4M | -$545.9M | -$542.1M | -$544.6M |
| **Total Stockholders' Equity** | $157.9M | $153.8M | $155.8M | $160.8M | $156.7M | $159.0M | $162.8M | $160.3M |
| Total Equity | $157.9M | $153.8M | $155.8M | $160.8M | $156.7M | $159.0M | $162.8M | $160.3M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | $4.16M | $18.62M | $26.92M | -$6.11M | -- |
| **Operating Cash Flow** | -$67.33M | $16.10M | -$20.71M | -$29.30M | $95.13M |
| Share Repurchases | -$801K | -$2.37M | -$1.06M | -$16.96M | -$8.20M |
| Dividends Paid | -$2.89M | -$2.65M | -- | -$266K | -- |
| **Financing Cash Flow** | $7.05M | $45.48M | $3.93M | -$17.37M | -$82.22M |
| **Net Change in Cash** | -$60.28M | $61.58M | -$16.78M | -$46.67M | $12.91M |

### Cash Flow Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $4.22M | $1.13M | -$4.77M | $4.08M | -$1.50M | -$896K | $2.46M | $6.10M |
| **Operating Cash Flow** | -$694K | $2.71M | -$2.04M | -$2.97M | -$6.88M | $8.79M | -$66.27M | $8.71M |
| Share Repurchases | -$31K | -$3.14M | -$183K | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | -$203K | -$3.04M | -$1.84M | $2.99M | $5.46M | -$7.29M | $5.88M | $49.99M |
| **Net Change in Cash** | -$897K | -$332K | -$3.88M | $19K | -$1.42M | $1.50M | -$60.38M | $58.71M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Return on Equity (ROE) | 2.6% | 11.6% | 18.3% | -5.1% |
| Return on Assets (ROA) | 1.3% | 6.1% | 11.2% | -2.8% |
| Debt to Equity | 0.02x | 0.00x | -- | -- |
| **Net Income Growth (YoY)** | -77.7% | -30.8% | -- | -- |
| EPS Growth (YoY) | -77.4% | -29.1% | -- | -- |
| Operating Cash Flow Growth (YoY) | -518.1% | -- | -- | -130.8% |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | 3.0% | -0.7% | -2.0% | 2.6% | 3.9% | 6.5% | 10.2% | 11.6% |
| Return on Assets (ROA) | 1.5% | -0.3% | -1.0% | 1.3% | 2.0% | 3.4% | 5.3% | 6.1% |
| Debt to Equity | 0.02x | 0.02x | 0.02x | 0.02x | 0.00x | 0.00x | -- | 0.00x |
| **Net Income Growth (YoY)** | -- | -- | -293.6% | -33.1% | -157.4% | -116.7% | -45.6% | -- |
| EPS Growth (YoY) | -- | -- | -295.1% | -- | -157.4% | -116.8% | -44.3% | -- |
| Operating Cash Flow Growth (YoY) | -- | -69.2% | -- | -134.1% | -- | -1.9% | -1081.1% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
